Clinical trial · Observational
PET on Surgery for Loco-regionally Recurrent Colorectal Cancer
Impact of Positron-Emission-Tomography on the Surgical Treatment for Loco-regionally Recurrent Colorectal Cancer
NCT05924282CI-TRIAL-00067795completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The influence of Positron-Emission-Tomography (PET) on the surgical treatment of loco-regionally recurrent colorectal cancer (LRRCRC) remains obscure and deserves further investigation.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Loco-regional Recurrent Colorectal Cancer | — | UNRESOLVED | — |
| PET-driven Surgery | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Curative intent surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Sole PET group
- description
- Tumor recurrence was detected solely by PET; the surgery was performed and the extent of the resection was guided by the PET.
- interventionNames
- Procedure: Curative intent surgery
- label
- Combined CT/MRI plus PET group
- description
- Tumor recurrence was detected by computed tomography (CT) / magnetic resonance imaging (MRI) and PET; the surgery was performed and the extent of the resection was guided by the CT/MRI+PET.
- interventionNames
- Procedure: Curative intent surgery
- label
- Control group
- description
- Tumor recurrence was detected but no surgery was performed.
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: i. patients with primary colorectal cancers undergoing R0 resection ii. Patients with final histopathologic reports documenting the pathologic Tumor-Node-Metastasis (pTNM) stage I, II, or III Exclusion Criteria: i. Patients with pTNM stage IV primary colorectal cancer ii. Patients with R1/2 resection
References
Publications (0)
Data not yet available
No reference posted for this study.